Enzo Biochem, Inc.
OTC: ENZB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Kara Cannon
- Employees
- 125
- Headquarters
- New York City, United States
- IPO year
- 1980
- Market cap
- $36.6M
- Website
- https://www.enzo.com
Loading ENZB…
Loading profile data…Frequently asked questions about ENZB
What does Enzo Biochem, Inc. (ENZB) do?
Enzo Biochem, Inc. operates as an integrated entity encompassing diagnostics, clinical laboratory services, and life sciences. The company is dedicated to developing, manufacturing, and commercializing diagnostic and research products, fundamentally rooted in genetic engineering, biotechnology, and molecular biology. Its operations are organized...
Where does ENZB trade?
Enzo Biochem, Inc. (ENZB) trades on the Other OTC.
What sector is ENZB in?
Enzo Biochem, Inc. (ENZB) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Enzo Biochem, Inc.?
Kara Cannon is the chief executive officer of Enzo Biochem, Inc. (ENZB).
Where is Enzo Biochem, Inc. headquartered?
Enzo Biochem, Inc. is headquartered in United States.
Does ENZB pay a dividend?
Yes — Enzo Biochem, Inc. (ENZB) paid a trailing twelve-month dividend of USD 0.40 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ENZB go public?
Enzo Biochem, Inc. (ENZB) completed its initial public offering in 1980.